ATYR
ATYR
NASDAQ · Biotechnology

Atyr Pharma Inc

$0.90
+0.09 (+10.89%)
As of Feb 8, 2:13 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 12.75M 11.28M 11.12M
Net Income 2.52M 2.04M 2.05M
EPS
Profit Margin 19.8% 18.1% 18.5%
Rev Growth -0.1% +22.8% +18.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 12.41M 10.29M 11.21M
Total Equity 50.25M 51.15M 53.31M
D/E Ratio 0.25 0.20 0.21
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 3.36M 2.88M 2.97M
Free Cash Flow 1.75M 1.40M 1.41M